Sjogren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia

被引:57
作者
Mignogna, MD
Fedele, S
Lo Russo, L
Lo Muzio, L
Wolff, A
机构
[1] Univ Naples Federico II, Sect Oral Med, Dept Odontostomatol & Maxillofacial Sci, Naples, Italy
[2] Univ Ancona, Inst Odontostomatol Sci, I-60128 Ancona, Italy
[3] Assuta Hosp, Hosp Dent Dept, Tel Aviv, Israel
[4] Maccabi Healthcare Serv, Tel Aviv, Israel
关键词
early diagnosis; hyposalivation; natural history; Sjogren's syndrome; xerostomia;
D O I
10.1111/j.1600-0714.2004.00264.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Sjogren's syndrome (SS) is a systemic autoimmune exocrinopathy that affects mainly the salivary and lacrimal glands, leading to progressive reduction in saliva and tear flow. Although the underlying immuno-mediated glandular destruction is thought to develop slowly over several years, a long delay from the start of the symptoms to final diagnosis has been frequently reported. A limited knowledge concerning SS natural history is among the major causes of the actual diagnostic delay. Although very few studies have been focused on the analysis of SS early clinical onset, a series of oral features preceding xerostomia/hyposalivation development in patients eventually diagnosed as having SS have been reported. Sialochemistry alterations, salivary gland swelling, early dental loss and sialorrhea have been observed before the onset of typical signs and symptoms (namely xerostomia and/or hyposalivation), which usually lead to SS clinical presentation and diagnosis. Here we suggest, after evaluating available data, that the traditional 'untouchable' association between SS and xerostomia/hyposalivation might probably be reconsidered, and that astute clinicians should not underestimate the possible presence or development of SS in patients without xerostomia/hyposalivation and presenting these atypical early oral features.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 45 条
  • [31] Sialorrhoea as early oral clinical manifestation of primary Sjogren's syndrome?
    Mignogna, MD
    Fedele, S
    Lo Russo, L
    Lo Muzio, L
    [J]. RHEUMATOLOGY, 2003, 42 (09)
  • [32] SJOGRENS SYNDROME (SICCA SYNDROME) - CURRENT ISSUES
    MOUTSOPOULOS, HM
    CHUSED, TM
    MANN, DL
    KLIPPEL, JH
    FAUCI, AS
    FRANK, MM
    LAWLEY, TJ
    HAMBURGER, MI
    [J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (02) : 212 - 226
  • [33] Pedersen A M, 2001, Expert Opin Pharmacother, V2, P1415
  • [34] SKOPOULI FN, 1986, SCAND J RHEUMATOL, P22
  • [35] XEROSTOMIA - A NEGLECTED SYMPTOM
    SREEBNY, LM
    VALDINI, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (07) : 1333 - 1337
  • [36] SREEBNY LM, 1992, INT DENT J, V42, P291
  • [37] Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjogren's syndrome
    Steinfeld, SD
    Appelboom, T
    Delporte, C
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (08): : 2249 - 2251
  • [38] Primary and secondary Sjögren's syndrome in children--a comparative study
    Stiller M.
    Golder W.
    Döring E.
    Biedermann T.
    [J]. Clinical Oral Investigations, 2000, 4 (3) : 176 - 182
  • [39] Thomas E, 1998, BRIT J RHEUMATOL, V37, P1069
  • [40] Valtysdóttir ST, 2000, CLIN EXP RHEUMATOL, V18, P597